Liver fibrosis: Non-invasive assessment with MR elastography

NMR in Biomedicine

Volumn 19, Issue 2, 2006, Pages 173-179

  Huwart, Laurent ^a   Peeters, Frank ^a   Sinkus, Ralph ^b   Annet, Laurence ^a   Salameh, Najat ^a   ter Beek, Leon C ^c   Horsmans, Yves ^a   Van Beers, Bernard E ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSTITUT LANGEVIN   (France)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

Elastography; Liver; Liver fibrosis

Indexed keywords

BIOPSY; DISEASES; ELASTICITY; MAGNETIC RESONANCE; MECHANICAL WAVES; PATIENT TREATMENT; TISSUE; VISCOSITY;

CHRONIC LIVER DISEASE; ELASTOGRAPHY; LIVER BIOPSY; LIVER FIBROSIS; SHEAR ELASTICITY; SHEAR VISCOSITY;

BIOLOGICAL ORGANS;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ELASTICITY; ELASTOGRAPHY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MALE; MOTION; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIZATION; STATISTICAL SIGNIFICANCE; TRANSDUCER; VISCOSITY;

ADULT; ELASTICITY; FEASIBILITY STUDIES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHYSICAL STIMULATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STRESS, MECHANICAL; VIBRATION;

EID: 33645503670     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1030     Document Type: Article

References (35)

1. Poynard T, Yuen MF, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003; 362: 2095-2100.
2. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N. Engl. J. Med. 2001; 344: 495-500.
3. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481.
4. Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 1999; 30: 1529-1530.
5. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can. J. Gastroenterol. 2000; 14: 543-548.
6. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J. Hepatol. 2003; 39: 239-244.
7. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457.
8. Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand. J. Gastroenterol. 2003; 38: 427-432.
9. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 2002; 97: 2614-2618.
10. Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch. Intern. Med. 1979; 139: 667-669.
11. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525.
12. Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WH. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am. J. Dig. Dis. 1971; 16: 1082-1086.
13. Bataller R, Brenner DA. Liver fibrosis. J. Clin. Invest. 2005; 115: 209-218.
14. Friedman SL. Liver fibrosis - from bench to bedside. J. Hepatol. 2003; 38 (Suppl 1): S38-S53.
15. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075.
16. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36(4 Pt 1): 986-992.
17. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin. Chem. 1996; 42: 558-563.
18. Patel K, Lajoie A, Heaton S, Pianko S, Behling CA, Bylund D, et al. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J. Gastroenterol. Hepatol. 2003; 18: 253-257.
19. Fontana RJ, Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002; 36 (5 Suppl 1): S57-S64.
20. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Couzigou P, de Ledinghen V. Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350.
21. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 2003; 29: 1705-1713.
22. Yeh WC, Li PC, Jeng YM, Hsu HC, Kuo PL, Li ML, Yang PM, Lee PH. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med. Biol. 2002; 28: 467-474.
23. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
24. Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 1995; 269: 1854-1857.
25. Manduca A, Oliphant TE, Dresner MA, Mahowald JL, Kruse SA, Amromin E, Felmlee JP, Greenleaf JF, Ehman RL. Magnetic resonance elastography: non- invasive mapping of tissue elasticity. Med. Image Anal. 2001; 5: 237-254.
26. Dresner M, Fidler J, Ehman R. MR elastography of in vivo human liver. In Proceedings of the 12th Annual Meeting of ISMRM. ISMRM: Kyoto, 2004; 502.
27. Sinkus R, Tanter M, Catheline S, Lorenzen J, Kuhl C, Sondermann E, Fink M. Imaging anisotropic and viscous properties of breast tissue by magnetic resonance-elastography. Magn. Reson. Med. 2005; 53: 372-387.
28. Sinkus R, Tanter M, Xydeas T, Catheline S, Bercoff J, Fink M. Viscoelastic shear properties of in vivo breast lesions measured by MR elastography. Magn. Reson. Imaging 2005; 23: 159-165.
29. Paulsen KD, Van Houten EEW, Doyley MM, Weaver JB. Magnetic resonance elastography in the breast: initial reconstructions of damping coefficient. In Proceedings of IEEE International Symposium on Biomedical Imaging. IEEE: Washington, DC, 2002; 157-160.
30. French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20(1 Pt 1): 15-20.
31. Bedossa P. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-293.
32. Bland J, Altman DG. Statistics notes: measurement error. BMJ 1996; 313: 744.
33. Crawford J. Liver cirrhosis. In Pathology of the Liver, 4th edn, MacSween RN, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP (eds). Churchill Livingstone: London, 2002; 575-620.
34. Van Beers BE, Materne R, Annet L, Hermoye L, Sempoux C, Peeters F, Smith AM, Jamart J, Horsmans Y. Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn. Reson. Med. 2003; 49: 692-699.
35. Salameh N, Sinkus R, Peeters F, Annet L, ter Beek LC, Van Beers BE. Assessment of liver fibrosis by MR-elastography - Voigt model and beyond (Kramers-Kronig). In Proceedings of the 22nd Annual Meeting of ESMRMB. ESMRMB: Basle, 2005; 67.